At least two US states will enact Right-to-Try or expanded access legislation explicitly naming ibogaine for veteran PTSD or TBI treatment before 2027-07-01

At least two US states will pass laws allowing veterans with PTSD or traumatic brain injury to access ibogaine outside normal FDA clinical trial rules (called right-to-try or expanded access). This matters because state legislatures can move faster than federal agencies, and the veteran community has real political power—both conservative and liberal lawmakers support veteran access to new treatments.

Texas and Florida have active veteran advocacy infrastructure, Republican governors receptive to veteran-framed legislation, and prior right-to-try precedent. State action is structurally faster than federal rescheduling. The Stanford ibogaine trial results published in 2024 provide the evidentiary hook legislators need. Dropping to two states (from three) reflects realistic legislative calendar constraints.